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We describe a new screening method for simultaneously 
detecting peptides that bind to a target protein by fluorescence 
obtained from fluorescent amino acid-modified peptides. 
A peptide library is generally used for screening peptides that 10 
bind to a target protein. The phage display method and the 
one-bead-one-compound method are widely used methods for 
screening with a peptide library.1-5 These methods essentially 
need to fix short peptides on very large carriers (sub-micron 
order) like phages and beads. This has a drawback because the 15 
large carriers often bind to the target protein nonspecifically 
and specific binding of peptides to the target protein is 
inhibited. To overcome this drawback, we have developed a 
new screening method for detecting peptides that bind to a 
target protein. This new method does not need carriers. 20 
Instead of carriers, multiple fluorescent amino acids are 
connected to peptides. The fluorescent amino acids are 
utilized as fluorescent tags in this method. Peptides that have 
bound to a target protein are instantaneously identified and 
quantified by fluorescence from the tags.  25 
 First, to examine whether a peptide that binds to a protein 
specifically can be detected by our method, we used a 
combination of a FLAG peptide (DYKDDDDK) and an anti-
FLAG antibody. It is known that a FLAG peptide specifically 
binds to an anti-FLAG antibody.6 We prepared a FLAG 30 
peptide and its mutant peptides modified with a fluorescent 
amino acid as a fluorescent tag by conventional solid-phase 
peptide synthesis (SPPS).7,8 Fluorescent amino acids (Fmoc-
Ala(Acd)-OH, Fmoc-Glu(Edn)-OH, Fmoc-Ala(Bad)-OH, 
Fmoc-Lys(Cmr)-OH, Fmoc-Ala(Pyr)-OH, and Fmoc-35 
Ala(Ant)-OH) were purchased from Watanabe Chemical 
(Hiroshima, Japan).9 Chemical structures of peptides modified 
with a fluorescent tag and sequences of these peptides are 
shown in Fig. 1. Fl indicates a fluorescent amino acid. 
Chemical structures of fluorescent amino acids are also shown 40 
in Fig. 1. To improve water solubility, two glutamic acids are 
connected to the fluorescent amino acid. Xn (n = 1-8) 
indicates a natural amino acid. The 8-mer peptide consisting 
of Xn is a library moiety. A long spacer consisting of ethylene 
glycol units (Sp6) connects the fluorescent amino acid with 45 
the library moiety. Ac indicates an acetyl group. These 
peptides were identified by MALDI-TOF Mass (Acd(KDD); 
calcd. [M+H]+ = 1911.80, obsd. [M+H]+ = 1912.81, 
Cmr(DKD); calcd. [M+H]+ = 1991.85, obsd. [M+H]+ = 
1992.89, Pyr(KEE); calcd. [M+H]+ = 1946.85, obsd. [M+H]+ 50 
= 1947.71, Bad(KAD); calcd. [M+H]+ = 1917.83, obsd. 
[M+H]+ = 1918.94, Ant(AAA); calcd. [M+H]+ = 1749.78,  
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Fig. 1. Chemical structure of the peptide modified with a 55 
fluorescent tag and sequences of peptides. Chemical structures 
of fluorescent amino acids.9 
 
obsd. [M+H]+ = 1950.79, Edn(DDD); calcd. [M+H]+ = 
2011.75, obsd. [M+H]+ = 2012.69). A Cy3-labeled anti-FLAG 60 
M2 antibody and non-labeled anti-FLAG M2 antibody used in 
this study were purchased from Sigma-Aldrich (St Louis, MO, 
USA). 
 The peptides modified with a fluorescent tag and the Cy3-
labeled anti-FLAG M2 antibody were examined by two-65 
dimensional fluorescence (2D-FL) spectroscopy in 10 mM 
HEPES-NaOH buffer (pH 7.4, 150 mM NaCl) containing 50% 
MeOH as shown in Fig. 2. The fluorescent tags showed 
differences in maximum excitation/emission wavelengths 
(Acd(KDD): 403 nm/420 nm, Edn(DDD): 350 nm/480 nm, 70 
Bad(KAD): 485 nm/512 nm, Cmr(DKD): 327 nm/386 nm, 
Pyr(KEE): 344 nm/378 nm, Ant(AAA): 359 nm/408 nm, 
Cy3-labeled anti-FLAG M2 antibody: 555 nm/570 nm). We 
also examined the mixture of these six peptides (each 10.0 nM, 
30 pmol) and Cy3-labeled anti-FLAG M2 antibody (0.2 nM, 75 
0.6 pmol) by 2D-Fl spectroscopy (Fig. 2). Then 
concentrations of fluorescent tag-modified peptides in the 
mixture were estimated by a least-squares analysis of  
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Fig. 2. 2D-Fl spectra of fluorescent tag-modified peptides, a 
Cy3-labeled anti-FLAG M2 antibody and the mixture of these 
peptides (each 10 nM) and the antibody (0.2 nM) over the 5 
wavelength ranges of 300-600 nm for excitation and 305-650 
nm for emission in 10 mM HEPES-NaOH (pH 7.4, 150 mM 
NaCl) containing 50% MeOH at room temperature. 
 
 10 
 
Fig. 3. 2D-Fl spectrum of the fraction containing Cy3-labeled 
anti-FLAG M2 antibody obtained after gel filtration 
chromatography of the mixture of fluorescent tag-modified 
peptides and the Cy3-labeded anti-FLAG M2 antibody.  15 
 
fluorescent intensity in the 2D-Fl spectrum for the mixture on 
the basis of component spectra (2D-FL spectra for the 
fluorescent tag-modified peptides). Consequently, 
concentrations of these peptides in the mixture were 20 
successfully quantified by this method (Bad(KAD): 11.6 nM, 
Cmr(DKD): 10.8 nM, Pyr(KEE): 10.2 nM, Edn(DDD): 10.4 
nM, Ant(AAA): 14.5 nM, Acd(KDD): 8.8 nM and Cy3-
labeled anti-FLAG M2 antibody: 0.2 nM).10 The results 
indicate that fluorescence resonance energy transfer (FRET), 25 
quenching and aggregation between peptides did not occur 
under these conditions. The results also clarified that this 
method can distinguish and quantify peptides in the mixture. 
 Next, the Cy3-labeled anti-FLAG M2 antibody (50 nM, 5.0 
pmol), the non-labeled anti-FLAG M2 antibody (1 µM, 100.0 30 
pmol) and the six peptides (each 1 µM, 100.0 pmol) were 
mixed in 10 mM HEPES-NaOH buffer (pH 7.4, 150 mM 
NaCl). After overnight incubation at 4 °C, the mixture was 
fractionated by Superdex 75pg size exclusion chromatography 
(GE Healthcare, London, UK). A 2D-FL spectrum for the 35 
fraction containing the Cy3-labeled anti-FLAG M2 antibody  
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Fig. 4. Sequences of the peptides modified with a fluorescent 
tag and chemical structures of the fluorescent amino acids.18 40 
 
was measured as shown in Fig. 3. Concentrations of all of the 
components were determined by the protocol described above. 
Acd(KDD) (FLAG peptide modified with Acd: 44.1 pmol) 
was detected together with a nearly equimolar amount of the 45 
anti-FLAG M2 antibody (54.0 pmol, estimated from 
fluorescence intensity of Cy3). We estimated the dissociation 
constant (Kd) of Acd(KDD)/anti-FLAG antibody complex by 
using least-squares analysis of fluorescent intensity for 
fractions in which the complex was observed. The Kd value 50 
was 17 × 10-9 M, which corresponds to a literature report of 
Kd (6.5 ×10-9 M)11. The somewhat higher value may be 
because of nonspecific adsorption of these peptides and/or the 
protein to gel by using gel filtration. Other peptides were not 
detected in the fraction (Edn(DDD): 8.1 pmol, Bad(KAD): 55 
5.7 pmol, Pyr(KEE): 0.6 pmol, Cmr(DKD): < 0 pmol, 
Ant(AAA): < 0 pmol). This result indicates that the method 
can be utilized as a method for detecting a pepitde that binds 
to a protein specifically. 
 We preliminarily examined screening for EGFR-binding 60 
peptides by this method. An EGFR (epidermal growth factor 
receptor)12,13 is a cell-surface receptor, and mutations 
affecting EGFR expression or activity can result in cancer. 
Therefore, an EGFR-binding peptide is an attractive medical 
tool, and some research groups screened for such a peptide by 65 
phase display methods.14-17  
 In this study, the extracellular domain of human EGFR 
fused to the Fc region of human IgG via a linker peptide (R & 
D Systems, Minneapolis, MN, USA) was used as a target 
protein. Seven fluorescent tag-modified peptides were newly 70 
synthesized by SPPS. Fluorescent amino acids (Fmoc-
Lys(Moc)-OH, Fmoc-Lys(Mac)-OH, Fmoc-Lys(Tmr)-OH, 
Fmoc-Orn(Cm3)-OH, Fmoc-Lys(Fam)-OH and Fmoc-
Lys(Hoc)-OH) were used as fluorescent tags on SPPS.18 
Fmoc-Lys(Tmr)-OH and Fmoc-Lys(Fam)-OH were purchased 75 
from ABD Bioquest (Sunnyvale, CA, USA) and other 
fluorescent amino acids were newly synthesized (See ESI). 
Sequences of these peptides and chemical structures of 
fluorescent amino acids are shown in Fig. 4.  
 These peptides were examined by 2D-FL spectroscopy in 80 
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10 mM HEPES-NaOH (pH 7.4, 150 mM NaCl) containing 
50% MeOH (maximum excitation/emission wavelengths: 348 
nm/400 nm for Moc(G/A/V), 377 nm/464 nm for Mac(I/L/M), 
401 nm/421 nm for Acd(S/T), 411 nm/451 nm for Hoc(D/E), 
446 nm/491 nm for Cm3(N/Q/P), 501 nm/524 nm for 5 
Fam(H/K/R), 542 nm/569 nm for Tmr(F/W/W)). Then these 
peptides were mixed with an EGFR in 10 mM HEPES-NaOH 
buffer (pH 7.4, 150 mM NaCl), and the mixture was incubated 
at 4 ˚C for 2 h. Final concentrations of the peptides were 190- 
 10 
Fig. 5. Quantities of the fluorescent tag-modified peptides and 
the EGFR estimated from 2D-FL spectra by least-squares 
analysis. 
 
280 µM (4.5-14 nmol) and the final concentration of the 15 
EGFR was 3.9 µM (190 pmol). The mixture was then 
fractionated by Superdex 75pg size exclusion chromatography. 
These fractions were measured by 2D-FL spectroscopy. 
Concentrations of all components in each fraction were 
quantified by the protocol described above. Quantities of the 20 
fluorescent tag-modified peptides and the EGFR in each 
fraction are shown in Fig. 5. The quantity of the EGFR was 
estimated from the fluorescence intensity at 333 nm 
(excitation at 280 nm). EGFR was detected in fraction 7 (46.3 
pmol) and fraction 8 (59.5 pmol) as shown in Fig. 5a. Free 25 
peptides were detected in the subsequent fractions. 
Fluorescent tag-modified peptides were also detected in 
fraction 7 (Fig. 5b; magnified fractions 5-9 in Fig. 5a). These 
results indicate that the peptides bind to EGFR and that the 
EGFR-binding peptides can be successfully detected by this 30 
method. Acd(S/T) (3.9 pmol), Tmr(F/Y/W) (2.3 pmol), 
Mac(I/L/M) (1.2 pmol) and Moc(G/A/V) (0.8 pmol) were 
detected in fraction 7. Other peptides were less than 0.4 pmol. 
These results indicate that specific peptides that bind to an 
EGFR can be successfully differentiated by this method. 35 
 In summary, we have developed a new method for 
screening peptides that bind to proteins. We synthesized 8-
mer peptides modified with a fluorescent amino acid. The 
peptides were mixed with an anti-FLAG antibody and an 
EGFR before incubation, and then the protein-binding 40 
peptides were recovered by gel filtration chromatography. The 
binding peptides were able to quantify simultaneously by this 
method. This method combines fluorescence analysis with gel 
filtration and it also will be able to combine the analysis with 
other separation techniques (capillary electrophoresis, 45 
ultrafiltration and affinity bead). Determination of an 8-mer 
peptide sequence that binds to an EGFR by this method is 
currently underway. 
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